Al­to Neu­ro­science and Fractyl Health add to biotech IPO mo­men­tum in Fri­day dou­ble­head­er

Two more biotechs will go pub­lic Fri­day morn­ing as Al­to Neu­ro­science and Fractyl Health build on the mo­men­tum cre­at­ed by CG On­col­o­gy and Ar­riVent Bio­Phar­ma’ …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER